Picture of Baxter International logo

BAX Baxter International Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual income statement for Baxter International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
R2021
December 31st
R2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue11,36211,67312,14614,50614,813
Cost of Revenue
Gross Profit4,8214,6354,7735,0925,317
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses10,34510,21310,85116,73714,476
Operating Profit1,0171,4601,295-2,231337
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes9701,2921,116-2,650-103
Provision for Income Taxes
Net Income After Taxes8171,1101,033-2,654-69
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income1,0011,1021,284-2,4332,656
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income1,0011,1021,284-2,4332,656
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS2.842.612.581.61.57
Dividends per Share